LegalView Features New Traumatic Brain Injury Treatment Information For U.S. Soldiers Using Diver's Therapy for Victims

(PRLEAP.COM) Denver, CO — LegalView recently reported up-to-date information on a potential new treatment for traumatic brain injury patients, specifically U.S. soldiers from the Iraq war, on its traumatic brain injury information blog.

The treatment that is being researched by medical and military professionals commonly treats a condition known as diver’s bends, which occurs when a diver is exposed to pressures that begin to increase without proper precautions. The treatment is known as hyperbaric oxygen therapy (HBOT) and occurs when an individual breaths "pure oxygen while in a sealed chamber that has been pressurized at 1.5 to 3 times normal atmospheric pressure," according to the American Cancer Society (ACS).

Scientists believe that when applied to a traumatic brain injury victim, HBOT may be able to relieve the pressures of an explosive blast-induced brain injury, which has become the signature wound of the Iraq war.

Individuals who have suffered from such an injury may find assistance in locating a brain injury law firm that can offer a plethora of brain injury lawyers and attorneys to choose from. A traumatic brain injury attorney may be able to offer a free legal consultation as to the potential development of a brain injury lawsuit.

LegalView also has available several additional legal information portals including what to do if involved in a truck accident and overcoming a mesothelioma diagnosis as well as information on the latest type 2 diabetes prescription drug known as Avandia.

According to the LegalView truck accident information portal, approximately 80,000 truck accidents occurred last year alone. Individuals who have been involved in a truck accident should seek medical attention, as many of the injuries deriving from a truck accident are internal and may not have signs and symptoms that are apparent until far too late for a truck accident victim.

Mesothelioma is a rare and destructive cancer that has been linked to the inhalation of asbestos fibers among individuals. Often, a mesothelioma diagnosis is delivered with little success for treating the condition as well as a grim life expectancy of one year. However, by contacting a mesothelioma attorney it may be possible to earn monetary compensation that could pay for experimental treatments of the condition. To learn more, visit http://mesothelioma.leaglview.com/

Additionally, LegalView offers information on the latest prescription drug controversies including the type 2 diabetes condition known as Avandia. Avandia has been linked to heart failure and bone fractures among patients, according to news reports from The New England Journal of Medicine. Patients consuming Avandia should speak with a medical professional and an experienced pharmaceutical attorney in order to avoid the harmful Avandia side effects associated with the drug.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation’s most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com’s superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.
Contact Information
Katie Kelley
LegalView.com
720-226-6613
Email LegalView.com

About This News Release

If you have any questions regarding information in these press releases please contact the organization listed in the press release. Issuers of press releases and not PR Leap are solely responsible for the accuracy of the content.

Share this News
PR Leap is a service of Condesa, Inc. © 2009 All Rights Reserved. Use of our service is governed by our Privacy Policy and Terms of Service.
Issuers of news releases are solely responsible for the accuracy of their content. Copyright / IP Policy